Padraic's Feed
May 20, 2013

Elan eyes more deals this year with $1 bln warchest

DUBLIN, May 20 (Reuters) – Elan will still have $1.2 billion
of cash left to spend if shareholders approve its first package
of acquisitions, and plans to announce more deals in the second
half of the year, chief executive Kelly Martin said on Monday.

Elan agreed on Monday to buy Austrian rare drug specialist
AOP Orphan for 263.5 million euros ($337 million) and pay $40
million for a 48 percent stake in Dubai-based sales and
marketing firm Newbridge pharmaceuticals.

May 18, 2013

Rugby-Toulon, Wilkinson delight in dismissing detractors

DUBLIN, May 18 (Reuters) – Toulon delighted in dismissing detractors who have accused them of buying success on Saturday when they were crowned European champions in a victory flyhalf Jonny Wilkinson said was as good as winning the World Cup.

Plying their trade in the second tier of French rugby just five years ago, the team from the Mediterranean capped their rapid rise in Dublin when they came from behind to beat Clermont Auvergne 16-15 for their first European title.

May 18, 2013

Rugby-Toulon are kings of Europe for first time

DUBLIN, May 18 (Reuters) – Toulon were crowned champions of Europe for the first time on Saturday when, aided by the boot of Jonny Wilkinson, they came from behind to beat Clermont Auvergne 16-15 in an all-French Heineken Cup final.

Outplayed for 60 minutes and seemingly out of the game after Clermont scored two tries in five blistering second-half minutes, big-spending Toulon stunned their rivals with a Delon Armitage try and a conversion by Wilkinson, playing in his first European final.

May 17, 2013

Leinster ease past Stade to clinch Europe’s second trophy

DUBLIN (Reuters) – Leinster won the Amlin Challenge Cup on Friday, twelve months after being crowned Heineken Cup champions, to deny Stade Francais a first piece of European silverware with an easy 34-13 victory.

Leinster, champions of Europe for three of the last four seasons, had to settle for a place in the second-tier of European rugby after failing to make it through the group stages of the Heineken Cup for just the second time in nine years.

May 17, 2013

Rugby-Leinster ease past Stade to clinch Europe’s second trophy

DUBLIN, May 17 (Reuters) – Leinster won the Amlin Challenge Cup on Friday, twelve months after being crowned Heineken Cup champions, to deny Stade Francais a first piece of European silverware with an easy 34-13 victory.

Leinster, champions of Europe for three of the last four seasons, had to settle for a place in the second-tier of European rugby after failing to make it through the group stages of the Heineken Cup for just the second time in nine years.

May 16, 2013

O’Driscoll gives Ireland and Leinster another year

DUBLIN (Reuters) – Ireland’s grand slam-winning captain Brian O’Driscoll ended months of uncertainty over his future on Thursday when he agreed to play on for one more year for province and country.

O’Driscoll, who will travel on his fourth British and Irish Lions tour next month, turned 34 this year and had said he would wait until July to decide on whether to call time on a glittering 14-year international career.

May 16, 2013

Rugby-O’Driscoll gives Ireland and Leinster another year

DUBLIN, May 16 (Reuters) – Ireland’s grand slam-winning captain Brian O’Driscoll ended months of uncertainty over his future on Thursday when he agreed to play on for one more year for province and country.

O’Driscoll, who will travel on his fourth British and Irish Lions tour next month, turned 34 this year and had said he would wait until July to decide on whether to call time on a glittering 14-year international career.

May 13, 2013

Elan strikes $1 billion royalty deal with Theravance

DUBLIN (Reuters) – Elan stepped up its bid to keep its independence on Monday by agreeing a $1 billion deal to buy 21 percent of the royalty that U.S. company Theravance receives from GlaxoSmithKline for its respiratory drugs.

The Irish drugmaker last month rejected a $5.7 billion bid from Royalty Pharma and has made a series of moves to frustrate the bid, contingent on 90 percent acceptance, since the U.S. investment firm declared its interest in February.

May 2, 2013

Elan considered buying Royalty before becoming its target

DUBLIN (Reuters) – Elan (ELN.I: Quote, Profile, Research, Stock Buzz)(ELN.N: Quote, Profile, Research, Stock Buzz) considered buying U.S. investment firm Royalty Pharma ROYPH.UL last year, six months before Royalty made its approach for the Irish drugmaker, the offer document for the bid showed on Thursday.

Royalty submitted its $5.7 billion bid on Thursday, standing by a reduced price in the face of Elan’s insistence it is worth more. Elan rejected the $11.25 per share bid last month and is determined to keep its independence.

Apr 30, 2013

Ireland proposes limited access to abortion amid heated debate

DUBLIN (Reuters) – Irish government ministers agreed draft legislation on Tuesday to allow for limited access to abortion where a woman’s life is in danger, including the threat of suicide, a proposal that has already divided the country’s ruling coalition.

Ireland’s two-decade-old debate over how the government should deal with a Supreme Court ruling that abortion be permitted when a woman’s life was at risk was re-opened last year following the death of a woman who was denied an abortion of her dying foetus.